← Back to Search

Self-Management Interventions for Long COVID

N/A

Recruiting

Led By Robin Green, PhD

Research Sponsored by Toronto Rehabilitation Institute

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up collected during each of the 8 session (1 sessions/week, 8 weeks)

Awards & highlights

No Placebo-Only Group

Summary

This trial aims to compare two different group interventions (education vs. mindfulness) to see which one is more effective in helping people manage Long-COVID symptoms.

Who is the study for?

This trial is for adults over 18 who have been clinically diagnosed with Long COVID-19, confirmed by a PCR test, and are experiencing persistent symptoms in mood, cognitive or somatic areas. Participants must speak English and have private internet access to join.

What is being tested?

The study compares two group-based self-management interventions for Long COVID: one focuses on mindfulness skills while the other provides education and strategies to manage symptoms.

What are the potential side effects?

Since the interventions involve non-medical approaches like mindfulness training and educational support, significant side effects are not expected. However, some participants might experience discomfort or emotional distress.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ collected during recruitment

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~collected during recruitment

This trial's timeline: 3 weeks for screening, Varies for treatment, and collected during recruitment for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Change in Adapted Illness Intrusiveness Rating

Change in Brief-COPE

Change in Kessler Psychological Distress Scale (K10)

+7 more

Secondary study objectives

Feasibility: Adherence rate

Feasibility: Recruitment rate

Feasibility: Retention rate

+2 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups

Experimental Treatment

Active Control

Group I: Education and Strategies Intervention GroupExperimental Treatment1 Intervention

Participants will use a videoconferencing system to participate in the Education and Strategies Intervention composed of 1 session per week (1.5 hrs/session) over the course of 8 weeks.

Group II: No-Treatment Control GroupActive Control1 Intervention

Participants adhere to the standard of care (no study treatment) for 8 weeks.

Group III: Mindfulness Skills Intervention GroupActive Control1 Intervention

Participants will use a videoconferencing system to participate in the Mindfulness Skills Intervention composed of 1 session per week (1.5 hrs/session) over the course of 8 weeks.

Do I qualify?Apply below to find out